Psychedelic substances are often stigmatized due to their hallucinogenic properties. However, alumni Chris Witowski, PhD, and Jackie von Salm, PhD, aim to change this perception. Through their company , they are developing non-hallucinogenic drugs that harness the therapeutic benefits of psychedelics, offering new treatment options for mental health disorders.
With support from the ºÚÁÏÍø³Ô¹Ï±¬ÁÏPresidential and Honors Scholarships, von Sal